论文部分内容阅读
目的 :探究神经节苷脂钠联合高压氧治疗新生儿缺氧缺血性脑病的临床疗效。方法 :抽取2015年6月--2016年6月在我院就诊的100例新生儿缺氧缺血性脑病患儿进行临床研究,随机将患儿分为观察组与对照组,各50例,观察组患者接受神经节苷脂钠联合高压氧治疗,对照组患儿接受常规治疗,观察比对两组患儿的临床疗效。结果 :经治疗后,观察组患儿临床有效率、临床症状改善情况显著优于对照组,具有统计学差异(P<0.05)。结论:神经节苷脂钠联合高压氧治疗新生缺氧缺血性脑病具有显著疗效,安全有效、临床效果良好、操作简单,可在临床中加以推广。
Objective: To investigate the clinical effect of ganglioside combined with hyperbaric oxygen on neonatal hypoxic-ischemic encephalopathy. Methods: A total of 100 neonates with hypoxic-ischemic encephalopathy were treated in our hospital from June 2015 to June 2016. The children were randomly divided into observation group and control group, 50 cases in each group, Patients in the observation group received ganglioside sodium combined with hyperbaric oxygen therapy, while children in the control group received conventional therapy. The clinical effects of the two groups were compared. Results: After treatment, clinical efficacy and clinical symptom improvement in observation group were significantly better than those in control group, with statistical significance (P <0.05). Conclusion: Ganglioside combined with hyperbaric oxygen therapy has a significant effect on neonatal hypoxic-ischemic encephalopathy, which is safe and effective. The clinical effect is good and the operation is simple. It can be popularized clinically.